Orum Therapeutics
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Orum Therapeutics
Create your alert
to follow the executive moves at Orum Therapeutics.
Biotechnology
Orum Therapeutics has 2,330 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).
Popular M&A news in Biotechnology
- Nuvig Therapeutics has just announced a $161 Million fundraising (posted on December 5 2024).
- March Biosciences has just announced a $28 Million fundraising (posted on December 3 2024).
- Lyell Immunopharma has acquired ImmPACT Bio (posted on November 29 2024).
Popular contacts in Biotechnology
News
Press releases by Orum Therapeutics
- Orum Therapeutics Selected for the 2024 Venture 100 Billion Won Companies Club by the Korean Ministry of SMEs and Startups — Orum Therapeutics
- Orum Therapeutics news — Orum Therapeutics
- Notice of New Share Issuance for KOSDAQ Listing — Orum Therapeutics
- Orum Therapeutics news — Orum Therapeutics
- Orum Therapeutics news — Orum Therapeutics
- Orum Therapeutics Submits Registration Statement for KOSDAQ Listing — Orum Therapeutics
- Orum Therapeutics Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of Orum’s TPD²® Technology to Develop Novel Degrader-Antibody Conjugates — Orum Therapeutics
- Orum Therapeutics news — Orum Therapeutics
- Orum Therapeutics Announces Acquisition of ORM-6151 Program by Bristol Myers Squibb — Orum Therapeutics
- Orum Therapeutics Unveils New Program At AACR 2023, Highlighting Cbl-B Inhibitor-PD-1 Conjugate, And Presents New Data Supporting Clinical Development Of Two GSPT1 Programs — Orum Therapeutics
- View more press releases Close
Social media about Orum Therapeutics
- Orum Therapeutics on Wikipedia, Google News & Yahoo Finance
- Orum Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Sung-Joo Lee 
Call Orum Therapeutics at +82 42...
